Main Article Content
Abstract
Peer-led psychosocial support interventions represent a potentially transformative approach to addressing the dual burden of diminished quality of life and enacted, anticipated, and internalized stigma among tuberculosis (TB) patients. Evidence from rigorous trials remains inconsistent, warranting a systematic synthesis. A systematic review and meta-analysis following PRISMA 2020 guidelines examined randomised controlled trials, quasi-experimental designs, and observational studies evaluating peer-led or community-based interventions in adults with TB. Searches covered PubMed, EMBASE, Global Health, CINAHL, and regional databases through March 2026. Risk of bias was assessed using study-design-specific tools (RoB 2.0 for RCTs, NOS for observational studies, MRAT for reviews). We conducted separate random-effects meta-analyses for two primary outcomes: quality of life and stigma reduction, using Hedges' standardised mean difference (SMD) with DerSimonian-Laird estimation. GRADE certainty assessment was performed. Twelve effect sizes from seven studies (N=1,449 across primary outcomes, with two contributing systematic reviews) were included. Quality of life improved significantly (k=6, SMD=0.3899, 95% confidence interval [0.2911, 0.4886], p<0.001, I²=0.00%, Tau²=0). Stigma reduction also reached statistical significance (k=6, SMD=−0.4175, 95% CI [−0.5208, −0.3142], p<0.001, I²=0.00%, Tau²=0). The overall pooled estimate across both outcomes was non-significant (SMD=−0.0273, 95% CI [−0.2925, 0.2379], p=0.8399), reflecting outcome-specific effects rather than universal benefit. Sensitivity analyses excluding systematic reviews and by study design confirmed directional consistency. Publication bias assessment (Egger's t=−0.26, p=0.80) revealed no evidence of small-study bias. GRADE ratings: moderate certainty for quality of life (due to design heterogeneity), moderate certainty for stigma reduction. In conclusion, peer-led psychosocial support interventions demonstrate efficacy for both quality of life enhancement and stigma reduction in TB patients. The zero heterogeneity finding (I²=0%) warrants cautious interpretation and suggests consistency despite implementation heterogeneity. Clinical integration requires standardised training, fidelity monitoring, and measurement protocols. Future research must employ larger, multi-country pragmatic trials with mechanistic substudies and long-term follow-up.
Keywords
Article Details
Open Access Indonesia Journal of Social Sciences (OAIJSS) allow the author(s) to hold the copyright without restrictions and allow the author(s) to retain publishing rights without restrictions, also the owner of the commercial rights to the article is the author.
